Releases - Scandinavian Clinical Nutrition

View:
 

Found press releases

 

First shipment of Immulina delivered to SCN’s new Immulina partner Aerus

9/3/2009 7:00 AM EST
In accordance to plan SCN has now received and delivered the first order from Aerus, SCN’s new Immulina partner, on totally USD 480 000 with cash payment. Aerus has also committed to purchase Immulina at a value of MSEK 250 during the coming five years in order to maintain the world-wide distribution rights. SCN also expects others order of the same size during this year.

Interim Report Q2 2009 from SCN

8/28/2009 2:55 AM EST
Scandinavian Clinical Nutrition, listed on NGM Equity and Oslo Axess, today releases the Q2 interim report for 2009. The entire report can be found in the attached pdf file, and on the company's website www.scnutrition.com.
April-June 2009 in brief for the SCN group
• Net sales for the period amounted to MSEK 7.0
• EBIT amounted to MSEK -11.3
• Loss for the period amounted to MSEK -4.8
• Earnings per share,...

Regarding Trade in SCN Shares on NGM Equity

8/24/2009 11:20 AM EST
As previously communicated, Scandinavian Clinical Nutrition AB (SCN) has applied for and been granted de-listing from Oslo Axess in Norway. From September 18 onwards, the SCN share will therefore only be traded on NGM Equity in Sweden, which may bring about certain changes for shareholders whose shares are registered in VPS in Norway.
On August 18, 2009, SCN and Oslo Börs communicated that Oslo Börs had decided...

SCN Signs Major World-Wide Distribution Agreement for Patented Immune Product

8/20/2009 7:00 AM EST
Scandinavian Clinical Nutrition AB (SCN) through its subsidiary has entered into a wide-ranging marketing and distribution agreement with US-based Aerus, formerly Electrolux North America. The agreement gives the direct sales company of Aerus Holdings, Naturals for Life, the world-wide exclusive rights to sell SCN’s patented immune product Immulina as a food supplement, with exception for markets where SCN already...

SCN Leaves Oslo Axess

8/18/2009 3:15 AM EST
As previously communicated, SCN has applied for de-listing of the company’s shares from the Norwegian Oslo Axess list. On August 17, 2009, Oslo Börs decided to approve the application. The last trading day for the SCN share on Oslo Axess will be September 17, 2009. The listing on NGM Equity remains unchanged.
As previously communicated, an extraordinary general meeting in Scandinavian Clinical Nutrition AB...

Financial Calendar for SCN 2009-2010

8/13/2009 2:45 AM EST
The Board of Scandinavian Clinical Nutrition i Sverige AB (publ) has decided on the following calendar for 2009-2010: November 13, 2009 Interim Report July-September (Q3, 2009) February 26, 2010 Year-end Report and Interim Report October-December (Q4, 2009) April 22, 2010 Interim Report January-March (Q1, 2010) June 22, 2010 Annual General Meeting

Publication of Prospectus from SCN

8/13/2009 2:30 AM EST
Today, August 12, 2009, Scandinavian Clinical Nutrition i Sverige AB (publ) publishes a prospectus regarding admission to trading of shares on NGM Equity due to the previously communicated directed share issue and issue of 3,700,000 shares.
As previously communicated, at June 30, 2009, the Board of SCN decided to increase the company’s share capital through a directed share issue by virtue of authorization from...

Directed Share Issue in SCN to Settle Claim from Loan

7/1/2009 2:45 AM EST
A consortium of investors have offered Scandinavian Clinical Nutrition AB (SCN) an interest free loan, payable with shares in SCN. The Board of SCN has accepted the offer, and therefore decided to issue a maximum of 3,200,000 shares in SCN at a price of SEK 1 per share to the consortium, by virtue of authorization from the 2009 Annual General Meeting.
In accordance with SCN’s previously communicated strategy...

Norwegian Investor Elected New Member of the Board by the SCN Annual General Mee...

6/26/2009 7:15 AM EST
At the Annual General Meeting in Scandinavian Clinical Nutrition i Sverige AB (publ) today, the Norwegian investor Tore Eiklid was elected new Member of the Board.
“I am very glad to announce that Tore Eiklid has been elected new Member of the Board of SCN. He has extensive experience of the international financial market and a vast network, especially in Norway, and will be a very good complement to the other...

SCN Plans to Sell Additional Shares in Scandivir

6/18/2009 3:50 AM EST
As communicated to the market in previous press releases, for example on March 30, 2009, Scandinavian Clinical Nutrition AB (SCN) has sold parts of the company’s shareholding in Scandivir AB in order to strengthen the company’s financial situation. With reference to the article in the Norwegian financial magazine Finansavisen today, SCN hereby clarifies that the company plans to sell additional parts or all of the...

Scandinavian Clinical Nutrition

Scandinavian Clinical Nutrition AB (publ) works in R&D and distribution of clinically tested, scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a produc...

View more


  CONTACT